HighTower Advisors
TXG icon

HighTower Advisors’s 10x Genomics TXG Stock Holding History

HighTower Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,000
Closed -$8.5K – 3972
2025
Q3 		$8.5K Buy
+20,000
New +$261K ﹤0.01% 3707

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighTower Advisors's TXG Position: Q2 2026 in Review

HighTower Advisors opened a new position in 10x Genomics (TXG) in Q2 2026: 16,752 shares worth $642K. The stake represents ﹤0.01% of the portfolio and ranks #2553 among its holdings. This is a return to the name: HighTower Advisors previously reported a position in TXG as recently as Q3 2025.

HighTower Advisors first reported a position in TXG in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.73M in Q1 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • HighTower Advisors held 16,752 shares of 10x Genomics worth $642K as of Q2 2026.
  • 10x Genomics was a new HighTower Advisors position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2553 holding.
  • HighTower Advisors first reported a position in 10x Genomics in Q2 2020 and has held it in 12 quarters since.
  • HighTower Advisors's 10x Genomics position peaked at $1.73M in Q1 2021.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.